A useful biospecimen request gives a supplier enough information to assess fit and enough flexibility to explain the available options. Start with the study’s requirements, then distinguish the criteria that are essential from those you can discuss.

Define the cohort before the quantity

Name the tissue or anatomical site, diagnosis or indication, and the clinical characteristics that determine whether a specimen can be used. If stage, molecular markers, treatment history, or a control population matters, say so explicitly.

State whether the count refers to patients, specimens, blocks, or slides. Ten slides from one block are a different request from material from ten independent donors. Where multiple materials must come from the same patient, describe that relationship.

Describe the material and acceptance criteria

Specify the preparation and format: for example, FFPE blocks, unstained slides, or another required material. Include the quantity of usable material needed for the planned work and any study-specific acceptance criteria. For matched tumor/normal pairs, describe the tissue relationship and whether associated data must come from the same donor.

Use these details to frame a Life Sciences enquiry.

Separate required attributes from preferences. If an alternative preparation or a staged delivery would work, make that visible. This gives the sourcing team a way to discuss feasibility without silently changing the research question.

Ask for the context you need

List the associated information required to interpret the material. That may include pathology confirmation, annotations, molecular information, or relevant outcomes. Specify which fields must be linked to the specimens and how missing information should be handled.

The National Cancer Institute describes biospecimen quality and the breadth of associated clinical information as important foundations for reliable research. Its biospecimen best practices provide broader context for planning a collection’s use.

If your study requires consented specimens, state the intended research use and the consent documentation you need to review. Include any requirements for institutional review board (IRB) approval or exemption documentation, provenance, and institutional release conditions.

These requirements depend on the collection and study. Establish what is available during feasibility; a specimen format alone does not establish permission to use it. Discuss the documentation during feasibility, before agreeing to fulfillment.

Make the next decision easy

Finish with your target timeline, delivery destination at an organizational level, and the person who can resolve scientific questions. A planning date is useful even when it is flexible.

A short opening brief could follow this structure:

We need [material] from [cohort], representing [number of patients]. Required attributes are [criteria]. We also need [linked information]. Our target delivery is [date], and we can discuss [acceptable alternatives].

Do not include patient identifiers in an initial website enquiry. Biobase’s request intake starts with the research requirements and uses the conversation to establish the next steps.